@incollection{,
	
					
					
					15E7CF88A19749D61646C6E97477F661
					,
	note={Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA)}
				,
	author={{AtinderpalKaur} and {I.S.F College of Pharmacy}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}1731120
}

@incollection{b0,
	
	
		,
	title={{Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study}}
		,
	author={{
			CJMurray
		} and {
			ADLopez
		}}
		
	
	
		,
	journal={{Lancet}}
		
			349
			
			,
	year={1997}
		
	

}

@incollection{b1,
	
	
		,
	title={{Global burden of cardiovascular diseases: Part I: general considerations, the epidemiologic transitions, risk factors and impact of urbanization}}
		,
	author={{
			SYusuf
		} and {
			SReddy
		} and {
			SOunpuu
		} and {
			SAnand
		}}
		
		
		
	
	
		,
	journal={{Circulation}}
		
			104
			
			,
	year={2001}
		
	

}

@incollection{b2,
	
	
		,
	title={{The thrombolysis and angioplasty in myocardial infarction. A randomized trail of late reperfusion therapy for acute myocardial infarction}}
		,
	author={{
			EJTopol
		} and {
			RMCalliff
		} and {
			MVandormael
		} and {
			CLGrines
		} and {
			BSGeorge
		} and {
			MLSanz
		}}
		
		
		
		
		
	
	
		,
	journal={{Circulation}}
		
			85
			
			,
	year={1992}
		
	

}

@incollection{b3,
	
	
		,
	title={{Role of bradykinin in preconditioning and protection of the ischaemic myocardium}}
		,
	author={{
			GFBaxter
		} and {
			ZEbrahim
		}}
		
	
	
		,
	journal={{Br J Pharmacol}}
		
			135
			
			,
	year={2002}
		
	

}

@incollection{b4,
	
	
		,
	title={{Heme oxygenase-1/ carbon monoxide: from basic science to therapeutic applications}}
		,
	author={{
			SWRyter
		} and {
			JAlam
		} and {
			AmkChoi
		}}
		
		
	
	
		,
	journal={{Physiol Rev}}
		
			85
			
			,
	year={2006}
		
	

}

@incollection{b5,
	
	
		,
	title={{Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium}}
		,
	author={{
			CEMurry
		} and {
			RBJennings
		} and {
			KAReimer
		}}
		
		
	
	
		,
	journal={{Circulation}}
		
			74
			
			,
	year={1986}
		
	

}

@incollection{b6,
	
	
		,
	title={{Ischemic Preconditioning in Humans: Models, Mediators, and Clinical Relevance}}
		,
	author={{
			FTomai
		} and {
			FCrea
		} and {
			LChiariello
		} and {
			PAGioffrè
		}}
		
		
		
	
	
		,
	journal={{Circulation}}
		
			100
			
			,
	year={1999}
		
	

}

@incollection{b7,
	
	
		,
	title={{Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits}}
		,
	author={{
			MVCohen
		} and {
			GSLiu
		} and {
			JMDowney
		}}
		
		
	
	
		,
	journal={{Circulation}}
		
			84
			
			,
	year={1991}
		
	

}

@incollection{b8,
	
	
		,
	title={{Signal Transduction in Ischemic Preconditioning: The Role of Kinases and Mitochondrial KATP Channels}}
		,
	author={{
			CPBaines
		} and {
			MVCohen
		} and {
			JMDowney
		}}
		
		
	
	
		,
	journal={{J Cardiovasc Electrophysiol}}
		
			10
			
			,
	year={1999}
		
	

}

@incollection{b9,
	
	
		,
	title={{Primary and secondary signalling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection}}
		,
	author={{
			EMurphy
		}}
	
	
		,
	journal={{Circ Res}}
		
			94
			
			,
	year={2004}
		
	

}

@incollection{b10,
	
	
		,
	title={{Dual Role of Phosphatidylinositol-3,4,5 trisphosphate in the activation of Protein Kinase B}}
		,
	author={{
			DStokoe
		} and {
			LRStephens
		} and {
			TCopeland
		} and {
			PRGaffney
		} and {
			CBReese
		} and {
			GFPainter
		}}
		
		
		
		
		
	
	
		,
	journal={{Science}}
		
			277
			
			,
	year={1997}
		
	

}

@incollection{b11,
	
	
		,
	title={{Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning and Postconditioning}}
		,
	author={{
			PFerdinandy
		} and {
			RSchulz
		} and {
			GFBaxter
		}}
		
		
	
	
		,
	journal={{Pharmacol Rev}}
		
			59
			
			,
	year={2007}
		
	

}

@incollection{b12,
	
	
		,
	title={{Role of endogenous nitric oxide in classic preconditioning in rat hearts}}
		,
	author={{
			MgmPrendes
		} and {
			MGonzalez
		} and {
			EASavino
		} and {
			AVarela
		}}
		
		
		
	
	
		,
	journal={{Reg Pept}}
		
			139
			
			,
	year={2007}
		
	

}

@incollection{b13,
	
	
		,
	title={{Heme oxygenase and cardiac function in ischemic/reperfused rat hearts}}
		,
	author={{
			CCsonka
		} and {
			EVarga
		} and {
			PKovas
		} and {
			PFerdinandy
		} and {
			IEBlasig
		} and {
			ZSzilvassy
		}}
		
		
		
		
		
	
	
		,
	journal={{Free Radic Biol Med}}
		
			27
			
			,
	year={1999}
		
	

}

@incollection{b14,
	
	
		,
	title={{Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/AKT/eNOS signaling pathway in diabetic myocardium}}
		,
	author={{
			SVPenumathsa
		} and {
			MThirunavukkarasu
		} and {
			LZhan
		} and {
			GMaulik
		} and {
			VPMenon
		} and {
			DBagchi
		}}
		
		
		
		
		
	
	
		,
	journal={{J Cell Mol Med}}
		
			12
			
			,
	year={2008c}
		
	

}

@incollection{b15,
	
	
		,
	title={{Ischemic preconditioning protection against stunning in conscious diabetic sheep: role of glucose, insulin, sarcolemmal and mitochondrial KATP channels}}
		,
	author={{
			DelValle
		} and {
			HFLascano
		} and {
			ECNegroni
		} and {
			JA
		}}
		
		
		
	
	
		,
	journal={{Cardiovasc Res}}
		
			55
			
			,
	year={2002}
		
	

}

@incollection{b16,
	
	
		,
	title={{Preconditioning the diabetic heart: the importance of Akt phosphorylation}}
		,
	author={{
			ATsang
		} and {
			DJHausenloy
		} and {
			MMMocanu
		} and {
			RDCarr
		} and {
			DMYellon
		}}
		
		
		
		
	
	
		,
	journal={{Diabetes}}
		
			54
			
			,
	year={2005}
		
	

}

@incollection{b17,
	
	
		,
	title={{Glimepiride reduces the threshold for ischemic preconditioning in the diabetic heart}}
		,
	author={{
			AWynne
		} and {
			DJHausenloy
		} and {
			MMMocanu
		} and {
			DMYellon
		}}
		
		
		
	
	
		,
	journal={{J Mol Cell Cardiol}}
		
			42
			
			,
	year={2007}
		
	

}

@incollection{b18,
	
	
		,
	title={{Diabetes Abolishes Morphine-Induced Cardioprotection via Multiple Pathways Upstream of Glycogen Synthase Kinase-3?}}
		,
	author={{
			ERGross
		} and {
			AKHsu
		} and {
			GJGross
		}}
		
		
	
	
		,
	journal={{Diabetes}}
		
			56
			
			,
	year={2007}
		
	

}

@incollection{b19,
	
	
		,
	title={{Involvement of GSK-3? in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart}}
		,
	author={{
			HNYadav
		} and {
			MSingh
		} and {
			PLSharma
		}}
		
		
	
	
		,
	journal={{Mol Cell Biol}}
		
			343
			
			,
	year={2010b}
		
	

}

@incollection{b20,
	
	
		,
	title={{Caveolae as organizers of pharmacologically relevant signal transduction molecules}}
		,
	author={{
			HHPatel
		} and {
			FMurray
		} and {
			PAInsel
		}}
		
		
	
	
		,
	journal={{Annu Rev Pharmacol Toxicol}}
		
			48
			
			,
	year={2007}
		
	

}

@incollection{b21,
	
	
		,
	title={{The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology}}
		,
	author={{
			RSOstrom
		} and {
			PAInsel
		}}
		
	
	
		,
	journal={{Br J Pharmacol}}
		
			143
			
			,
	year={2004}
		
	

}

@incollection{b22,
	
	
		,
	title={{Caveolin and the regulation of endothelial nitric oxide synthase in the heart}}
		,
	author={{
			OFeron
		} and {
			JLBalligand
		}}
		
	
	
		,
	journal={{Cardiovasc Res}}
		
			69
			
			,
	year={2006}
		
	

}

@incollection{b23,
	
	
		,
	title={{Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and glut-4}}
		,
	author={{
			SKoneru
		} and {
			SVPenumathsa
		} and {
			MThirunavukkarasu
		} and {
			SMSamuel
		} and {
			LZhan
		} and {
			ZHan
		}}
		
		
		
		
		
	
	
		,
	journal={{Am J Physiol Heart Circ Physiol}}
		
			292
			
			,
	year={2007}
		
	

}

@incollection{b24,
	
	
		,
	title={{Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression}}
		,
	author={{
			MBucci
		} and {
			FRoviezzo
		} and {
			VBrancaleone
		} and {
			MILin
		} and {
			ADLorenzo
		} and {
			CCicala
		}}
		
		
		
		
		
	
	
		,
	journal={{Arterioscler Thromb Vasc Biol}}
		
			24
			
			,
	year={2004}
		
	

}

@incollection{b25,
	
	
		,
	title={{Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications}}
		,
	author={{
			SWRyter
		} and {
			JAlam
		} and {
			AmkChoi
		}}
		
		
	
	
		,
	journal={{Physiol Rev}}
		
			85
			
			,
	year={2006}
		
	

}

@incollection{b26,
	
	
		,
	title={{Caveolae compartmentalization of heme oxygenase-1 in endothelial cells}}
		,
	author={{
			HPKim
		} and {
			XWang
		} and {
			FGalbiati
		} and {
			SWRyter
		} and {
			AMChoi
		}}
		
		
		
		
	
	
		,
	journal={{FASEB J}}
		
			18
			
			,
	year={2004}
		
	

}

@incollection{b27,
	
	
		,
	title={{Absence of Heme Oxygenase-1 Exacerbates Myocardial Ischemia/Reperfusion Injury in Diabetic Mice}}
		,
	author={{
			XLiu
		} and {
			JWei
		} and {
			DHPeng
		} and {
			MDLayne
		} and {
			SYet
		}}
		
		
		
		
	
	
		,
	journal={{Diabetes}}
		
			54
			
			,
	year={2005}
		
	

}

@incollection{b28,
	
	
		,
	title={{Daidzein and 17 beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1}}
		,
	author={{
			OLWoodman
		} and {
			MAMissen
		} and {
			MBoujaoude
		}}
		
		
	
	
		,
	journal={{J Cardiovasc Pharmacol}}
		
			44
			
			,
	year={2004}
		
	

}

@incollection{b29,
	
	
		,
	title={{HMox-1 constitute an adaptive response to effect antioxidant cardioprotection: a study with transgenic mice heterozygous for targeted disruption of the heme oxygenase-1 gene}}
		,
	author={{
			TYoshida
		} and {
			NMaulik
		} and {
			YSHo
		} and {
			JAlam
		} and {
			DKDas
		}}
		
		
		
		
	
	
		,
	journal={{Circulation}}
		
			103
			
			,
	year={2001}
		
	

}

@incollection{b30,
	
	
		,
	title={{Hemeoxygenase and cardiac function in ischemic/reperfused rat hearts}}
		,
	author={{
			CCsonka
		} and {
			EVarga
		} and {
			PKovas
		} and {
			PFerdinandy
		} and {
			IEBlasig
		} and {
			ZSzilvassy
		}}
		
		
		
		
		
	
	
		,
	journal={{Free Radic Biol Med}}
		
			27
			
			,
	year={1999}
		
	

}

@incollection{b31,
	
	
		,
	title={{Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice}}
		,
	author={{
			MLi
		} and {
			SPeterson
		} and {
			DHusney
		} and {
			MInaba
		} and {
			KGuo
		} and {
			AKappas
		}}
		
		
		
		
		
	
	
		,
	journal={{Cell Cycle}}
		
			6
			
			,
	year={2007}
		
	

}

@incollection{b32,
	
	
		,
	title={{Hemeoxygenase-1 and the ischemia-reperfusion injury in the rat heart}}
		,
	author={{
			EMasini
		} and {
			AVannacci
		} and {
			CMarzocca
		} and {
			SPierpaoli
		} and {
			LGiannini
		} and {
			OFantappie
		}}
		
		
		
		
		
	
	
		,
	journal={{Exp Biol Med (Maywood)}}
		
			228
			
			,
	year={2003}
		
	

}

@incollection{b33,
	
	
		,
	title={{Possible role of cardiac mast cell degranulation and preservation of nitric oxide release in isolated rat heart subjected to ischemic preconditioning}}
		,
	author={{
			VParikh
		} and {
			MSingh
		}}
		
	
	
		,
	journal={{Mol Cell Biochem}}
		
			199
			
			,
	year={1999}
		
	

}

@incollection{b34,
	
	
		,
	title={{Decrease of myocardial infarct size with desferroxamine. Possible role of oxygen free radicals in its ameliorative effect}}
		,
	author={{
			KChopra
		} and {
			MSingh
		} and {
			NKaul
		} and {
			NKGanguly
		}}
		
		
		
	
	
		,
	journal={{Mol Cell Biochem}}
		
			13
			
			,
	year={1992}
		
	

}

@incollection{b35,
	
	
		,
	title={{Long-term treatment with the apolipoprotein A1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats}}
		,
	author={{
			SJPeterson
		} and {
			DHusney
		} and {
			ALKruger
		} and {
			ROlszanecki
		} and {
			FRicci
		} and {
			LFRodella
		}}
		
		
		
		
		
	
	
		,
	journal={{J Pharmacol Exp Ther}}
		
			322
			
			,
	year={2007}
		
	

}

@incollection{b36,
	
	
		,
	title={{Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart}}
		,
	author={{
			PAjmani
		} and {
			H NYadav
		} and {
			MSingh
		} and {
			PLSharma
		}}
		
		
		
	
	
		,
	journal={{BMC Cardiovasc Disord}}
		
			11
			43
			,
	year={2011}
		
	

}

@incollection{b37,
	
	
		,
	title={{Nitrite confers protection against myocardial infarction: Role of xanthine oxidoreductase, NADPH oxidase and K ATP channels}}
		,
	author={{
			JEBaker
		} and {
			JSu
		} and {
			XFu
		} and {
			AHsu
		} and {
			GJGross
		} and {
			JSTweddell
		}}
		
		
		
		
		
	
	
		,
	journal={{J Mol Cell Cardiol}}
		
			43
			
			,
	year={2007}
		
	

}

@incollection{b38,
	
	
		,
	title={{The caveolin genes: from cell biology to medicine}}
		,
	author={{
			TMWilliams
		} and {
			MPLisanti
		}}
		
	
	
		,
	journal={{Ann Med}}
		
			36
			
			,
	year={2004}
		
	

}

@incollection{b39,
	
	
		,
	title={{Identification of peptide and protein ligands for the caveolinscaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins}}
		,
	author={{
			JCouet
		} and {
			MSargiacomo
		} and {
			MPLisanti
		}}
		
		
	
	
		,
	journal={{J Biol Chem}}
		
			272
			
			,
	year={1997}
		
	

}

@incollection{b40,
	
	
		,
	title={{Arteriolar nitric oxide concentration is decreased during hyperglycemiainduced beta II PKC activation}}
		,
	author={{
			HGBohlen
		} and {
			GPNase
		}}
		
	
	
		,
	journal={{Am J Physiol Heart Circ Physiol}}
		
			280
			
			,
	year={2001}
		
	

}

@incollection{b41,
	
	
		,
	title={{Daidzein and 17 beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1}}
		,
	author={{
			OLWoodman
		} and {
			MAMissen
		} and {
			MBoujaoude
		}}
		
		
	
	
		,
	journal={{J Cardiovasc Pharmacol}}
		
			44
			
			,
	year={2004}
		
	

}

@incollection{b42,
	
	
		,
	title={{Red wine polyphenol resveratrol regulates Heme Oxygenase-1 conversely for the disruption of Caveolin-1/eNOS platform and improve left ventricular function in Ischemic Hypercholesterolemic Myocardium}}
		,
	author={{
			SVPenumathsa
		} and {
			SKoneru
		} and {
			SMSamuel
		} and {
			LZhan
		} and {
			VPMenon
		} and {
			NMaulik
		}}
		
		
		
		
		
	
	
		,
	journal={{FASEB J}}
		
			22
			1130
			,
	year={2008b}
		
	

}